FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


14853 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Mental &/or developmental handicap screen Screening for developmental disorder (procedure)
Mental disorder - unspecified whether during pregnancy or the puerperium Mental disorders during pregnancy, childbirth and the puerperium
Mental disorder during pregnancy, childbirth or the puerperium NOS Mental disorders during pregnancy, childbirth and the puerperium
Mental handicap Intellectual disability
Mental handicap (specialty) Intellectual disability specialty
Mental handicap (specialty) Intellectual disability specialty
handicap mental (spécialité) Intellectual disability specialty
service de psychiatrie spécialisée dans le handicap mental Intellectual disability psychiatry department (environment)
service de psychiatrie en déficience mentale Intellectual disability psychiatry service
examen physique annuel en santé mentale effectué Annual physical examination for people with mental illness completed
Mental health crisis plan Mental health crisis plan
Mental health personal health plan Mental health personal health plan
retard mental Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation screening Intellectual disability screening
dépistage d'un handicap mental ou de développement Screening for developmental disorder (procedure)
Mental/developmental handicap screening NOS Screening for developmental disorder (procedure)
Mental/developmental handicap screening NOS Screening for developmental disorder (procedure)
Menthol 35.55mg inhalant capsule Product containing only menthol in pulmonary dose form (medicinal product form)
Mepacrine hydrochloride 100mg tablet Mepacrine hydrochloride 100 mg oral tablet
Meperidine hydrochloride 100mg/mL injection solution ampule Product containing only pethidine in parenteral dose form (medicinal product form)
Meperidine hydrochloride 50mg/5mL syrup Pethidine hydrochloride 10 mg/mL oral solution
Meperidine hydrochloride 50mg/mL injection solution ampule Product containing only pethidine in parenteral dose form (medicinal product form)
Meperidine hydrochloride 50mg/promethazine hydrochloride 50mg injection solution vial Product containing only pethidine and promethazine (medicinal product)
Mepivacaine hydrochloride 3%/levonordefrin 1:20,000 injection solution vial Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection
Mepivacaine hydrochloride 30mg/sodium chloride 3mg injection solution vial Mepivacaine only product
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Meptazinol 100mg/1mL injection Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 100mg/mL injection solution 1mL ampule Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 200mg tablet Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet
Mercurophylline injection Mercurophylline
Merselene patch Polyester mesh (physical object)
Mesalamine 250mg capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg m/r capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg m/r capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 1g/100mL retention enema Mesalazine only product in rectal dose form
Mesalazine 1g/100mL retention enema Mesalazine only product in rectal dose form
Mesalazine 2g/59mL enema Mesalazine only product in rectal dose form
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 500mg/sachet m/r granules Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine duplicate deleted Product containing mesalazine (medicinal product)
Mesenteric venous thrombosis Thrombosis of mesenteric vein
Mesio-occlusion Mesio-occlusion of teeth
Mesonephric tumor Wolffian tumor of uncertain behavior (morphologic abnormality)
Mesoridazine besylate 10mg/mL injection solution ampule Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesoridazine besylate 25mg/mL injection solution ampule Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesothelioma, biphasic, benign Mesothelioma, benign
Metabolic acidosis caused by ingestion of drugs AND/OR chemicals Metabolic acidosis
Metabolic disease, NEC Metabolic disease
Metabolic marker Inborn errors of metabolism marker
Metaiodobenzylguanidine[123I] 74MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[123I] 74MBq/mL powder for injection solution vial Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL powder for injection solution vial Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]370MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]37MBq/mL diagnostic injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]9.25MBq/mL diagnostic injection Iobenguane (131-I)-containing product in parenteral dose form
Metallocarboxypeptidase Metallocarboxypeptidase
Metalloproteinase Metalloproteinase (substance)
Metaproterenol 20mg tablet Orciprenaline sulfate 20 mg oral tablet
Metaproterenol sulfate 0.65mg/inh aerosol Orciprenaline only product in pulmonary dose form
Metaproterenol sulfate 15mg/mL aerosol Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Metastasis stage M1a American Joint Committee on Cancer cM1a (qualifier value)
Metastasis stage M1b American Joint Committee on Cancer cM1b (qualifier value)
Metastasis stage M1c cM1c
Metastasis stage M2 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M3 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M4 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage pM1 American Joint Committee on Cancer pM1 (qualifier value)
Metastasizing pleomorphic adenoma Pleomorphic adenoma
Metatarsal phalangeal joint flap Flap (substance)
Methacholine 2.5% eye drops Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug)
Methacholine chloride 100mg powder Product containing only methacholine (medicinal product)
Methadone 10mg/5mL mixture Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Methadone hydrochloride 40mg dispersible tablet Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Methamphetamine hydrochloride 10mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 10mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 15mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg m/r tablet Metamfetamine only product in oral dose form
Methamphetamine hydrochloride 5mg prolonged-release oral tablet Metamfetamine only product in oral dose form
Methods of operation NOC Surgical procedure (procedure)
Methods of operation NOC NOS Surgical procedure (procedure)
Methohexital sodium 5g powder for injection solution vial Product containing only methohexital (medicinal product)
Methoxsalen 20mcg/mL injection solution 10mL vial Methoxsalen 20 microgram/mL solution for injection
Methyl aminolevulinate 168mg/g topical cream Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream
Methyl methacrylate embolism Foreign body embolus
Methyl parathion Hexaethyl tetraphosphate
Methylcellulose 1% eye drops Methylcellulose 10 mg/mL eye solution
Methylene blue 1% injection solution vial Methylthioninium chloride only product in parenteral dose form
Methylene blue 65mg tablet Methylthioninium chloride 65 mg oral tablet
Methylenedioxymethamphetamine dependence with current use Methylenedioxymethamphetamine dependence
Methylobacterium animovorans Methylorubrum aminovorans (organism)
Methylobacterium lusitanum Methylorubrum rhodesianum (organism)
Methylphenidate 10mg chewable tablet Methylphenidate hydrochloride 10 mg chewable tablet
Methylphenidate 2.5mg chewable tablet Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug)

Start Previous Page 72 of 149 Next End


Reference Sets

Reference set descriptor

Back to Start